- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds | ||
| Fr | For Sanofi, Dupixent's surge overcomes shortfall in vaccine sales | ||
| Fr | Ipsen's educational push offers guidance to young adults switching from pediatric to adult healthcare | ||
| Fr | CF buyers club aims to grow access to Vertex's Trikafta through trade-policy workaround | ||
| Fr | Roche's Chugai strikes $200M M&A deal to take over IgAN asset in several Asian countries | ||
| Do | Lonza's recently purchased Calif. biologics site plays key role in sales rebound | ||
| Do | Astellas taps social media star Babs Costello to promote Izervay for geographic atrophy | ||
| Do | Havas Lynx presses pharma to pivot from 'selling to serving' to confront health misinformation | ||
| Do | Roche contends with loss of momentum for key medicines, currency fluctuations in Q3 but keeps growth on track | ||
| Do | With Nemluvio sales booming, Galderma pledges to spend $650M on US-based manufacturing | ||
| Do | Cambrex to drop $120M to expand US operations amid industry's breakneck onshoring drive | ||
| Mi | Merck KGaA to mothball operations at Ireland API plant by end of 2028 | ||
| Mi | J&J and the Jets: Pharma signs on as NFL team's medical innovation sponsor | ||
| Mi | Novartis sues AstraZeneca's Alexion over 'false and misleading' Ultomiris marketing | ||
| Mi | Moderna-backed ALA campaign takes a shot at boosting respiratory vaccine uptake | ||
| Mi | Alkermes plots $2.1B acquisition of Avadel and its long-acting narcolepsy drug Lumryz | ||
| Mi | Consolidating Novavax transfers Maryland HQ lease to AstraZeneca in $60M deal | ||
| Mi | Real Chemistry debuts AI tool to stay on top of FDA's torrent of marketing letters | ||
| Mi | Trump admin readies 'imminent' probe into other nations' drug pricing, raising new tariff threat: FT | ||
| Di | Exit Axial, enter Vertero: Biotech rebrands, refocuses and raises $20M | ||
| Di | Kenvue calls on FDA to reject proposed Tylenol safety warnings, pushes back on alleged autism link | ||
| Di | Novo Nordisk telegraphs board shakeup, with former CEO Lars Soerensen tapped to chair | ||
| Di | FDA expansion for Novo's Rybelsus is a new 'benchmark' for oral metabolism drugs | ||
| Di | Wilmington PharmaTech, on mission to boost US drug ingredient capacity, snares investment from PE firm Curewell | ||
| Di | India's ACG pumps $200M into its first US empty-capsule production facility |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .